Evidence map›Paper›PMID 39380801›Full record

ArticleCanada communicable disease report = Releve des maladies transmissibles au Canada2024

Mathematical modelling for pandemic preparedness in Canada: Learning from COVID-19.

Nicholas H Ogden, Emily S Acheson, Kevin Brown, David Champredon, Caroline Colijn, Alan Diener, Jonathan Dushoff, David Jd Earn, Vanessa Gabriele-Rivet, Marcellin Gangbè and 16 more

Abstract read
In one paragraph

Article in Canada communicable disease report = Releve des maladies transmissibles au Canada, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Nicholas H OgdenPublic Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada.
Emily S AchesonPublic Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada.
Kevin BrownPublic Health Ontario, Toronto, ON.
David ChampredonPublic Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada.
Caroline ColijnDepartment of Mathematics, Simon Fraser University, Burnaby, BC.
Alan DienerHealth Policy Branch, Health Canada, Ottawa, ON.
Jonathan DushoffDepartment of Biology and Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, ON.
David Jd EarnDepartment of Mathematics and Statistics and Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, ON.
Vanessa Gabriele-RivetPublic Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada.
Marcellin GangbèPublic Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada.
Steve GuillouzicCentre for Operational Research and Analysis, Defence Research and Development Canada, Department of National Defence, Ottawa, ON.
Deirdre HennessyHealth Analysis Division, Analytical Studies and Modelling Branch, Statistics Canada, Ottawa, ON.
Valerie HongohPublic Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada.
Amy HurfordDepartment of Biology and Department of Mathematics and Statistics, Memorial University of Newfoundland, St. John's, NL.
Lisa KanaryPublic Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada.
Michael LiPublic Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada.
Victoria NgPublic Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada.
Sarah P OttoDepartment of Zoology and Biodiversity Research Centre, University of British Columbia, Vancouver, BC.
Irena PapstPublic Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada.
Erin E ReesPublic Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada.
Ashleigh TuiteDalla Lana School of Public Health, University of Toronto, Toronto, ON.
Matthew R MacLeodCentre for Operational Research and Analysis, Defence Research and Development Canada, Department of National Defence, Ottawa, ON.
Carmen Lia MurallPublic Health Genomics Division, National Microbiology Laboratory, Public Health Agency of Canada.
Lisa WaddellPublic Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada.
Rania WasfiPublic Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada.
Michael WolfsonFaculty of Medicine and Faculty of Law-Common Law, University of Ottawa, Ottawa, ON.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The COVID-19 pandemic underlined the need for pandemic planning but also brought into focus the use of mathematical modelling to support public health decisions. The types of models needed (compartment, agent-based, importation) are described. Best practices regarding biological realism (including the need for multidisciplinary expert advisors to modellers), model complexity, consideration of uncertainty and communications to decision-makers and the public are outlined. Methods: A narrative review was developed from the experiences of COVID-19 by members of the Public Health Agency of Canada External Modelling Network for Infectious Diseases (PHAC EMN-ID), a national community of practice on mathematical modelling of infectious diseases for public health. Results: Modelling can best support pandemic preparedness in two ways: 1) by modelling to support decisions on resource needs for likely future pandemics by estimating numbers of infections, hospitalized cases and cases needing intensive care, associated with epidemics of "hypothetical-yet-plausible" pandemic pathogens in Canada; and 2) by having ready-to-go modelling methods that can be readily adapted to the features of an emerging pandemic pathogen and used for long-range forecasting of the epidemic in Canada, as well as to explore scenarios to support public health decisions on the use of interventions. Conclusion: There is a need for modelling expertise within public health organizations in Canada, linked to modellers in academia in a community of practice, within which relationships built outside of times of crisis can be applied to enhance modelling during public health emergencies. Key challenges to modelling for pandemic preparedness include the availability of linked public health, hospital and genomic data in Canada.

Indexed as

COVID-19infectious diseasesmathematical modellingpandemic preparedness

Identifiers

PMID39380801
PMCPMC11460797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.